Probiotics increase T regulatory cells and reduce severity of experimental colitis in mice

World Journal of Gastroenterology

Volumn 19, Issue 5, 2013, Pages 742-749

  Zhao, Hai Mei ^a   Huang, Xiao Ying ^a   Zuo, Zhi Qin ^a   Pan, Qi Hong ^a   Ao, Mei Ying ^a   Zhou, Feng ^a   Liu, Hong Ning ^a   Liu, Zhi Yong ^a   Liu, Duan Yong ^a  

^a JIANGXI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Cytokine; Probiotics; Ulcerative colitis

Indexed keywords

BIFICO; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; MESALAZINE; PROBIOTIC AGENT; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL INFILTRATION; COLITIS; CONTROLLED STUDY; DISEASE SEVERITY; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; HISTOLOGY; INFLAMMATION; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; ULCER; UPREGULATION;

EID: 84873658324     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i5.742     Document Type: Article

References (27)

1. Tsuda Y, Yoshimatsu Y, Aoki H, Nakamura K, Irie M, Fukuda K, Hosoe N, Takada N, Shirai K, Suzuki Y. Clinical effectiveness of probiotics therapy (BIO-THREE) in patients with ulcerative colitis refractory to conventional therapy. Scand J Gastroenterol 2007; 42: 1306-1311. [PMID: 17852859 DOI: 10.1080/00365520701396091]
2. Ochsenkühn T, D'Haens G. Current misunderstandings in the management of ulcerative colitis. Gut 2011; 60: 1294-1299. [PMID: 21504997 DOI: 10.1136/gut.2010.218180.]
3. Lewis JD, Gelfand JM, Troxel AB, Forde KA, Newcomb C, Kim H, Margolis DJ, Strom BL. Immunosuppressant medications and mortality in inflammatory bowel disease. Am J Gastroenterol 2008; 103: 1428-1435; quiz 1436. [PMID: 18494836 DOI: 10.1111/j.1572-0241.2008.01836.x]
4. Maul J, Zeitz M. Ulcerative colitis: immune function, tissue fibrosis and current therapeutic considerations. Langenbecks Arch Surg 2012; 397: 1-10. [PMID: 21479621 DOI: 10.1007/s00423-011-0789-4.]
5. Gionchetti P, Rizzello F, Lammers KM, Morselli C, Sollazzi L, Davies S, Tambasco R, Calabrese C, Campieri M. Antibiotics and probiotics in treatment of inflammatory bowel disease. World J Gastroenterol 2006; 12: 3306-3313. [PMID: 16733845]
6. Bloom SM, Bijanki VN, Nava GM, Sun L, Malvin NP, Donermeyer DL, Dunne WM, Allen PM, Stappenbeck TS. Commensal Bacteroides species induce colitis in host-genotypespecific fashion in a mouse model of inflammatory bowel disease. Cell Host Microbe 2011; 9: 390-403. [PMID: 21575910 DOI: 10.1016/j.chom.2011.04.009.]
7. Rust C, Brand S. PSC: Protect and serve with colitis: does it help the liver to have severe ulcerative colitis? Gut 2011; 60: 1165-1166. [PMID: 21561875 DOI: 10.1136/gut.2011.240309.]
8. Lagranderie M, Kluge C, Kiefer-Biasizzo H, Abolhassani M, Nahori MA, Fitting C, Huerre M, Bandeira A, Bercovier H, Marchal G. Mycobacterium bovis Bacillus Calmette-Guérin killed by extended freeze-drying reduces colitis in mice. Gastroenterology 2011; 141: 642-652, 652.e1-4. [PMID: 21683076 DOI: 10.1053/j.gastro.2011.05.002.]
9. Sujino T, Kanai T, Ono Y, Mikami Y, Hayashi A, Doi T, Matsuoka K, Hisamatsu T, Takaishi H, Ogata H, Yoshimura A, Littman DR, Hibi T. Regulatory T cells suppress development of colitis, blocking differentiation of T-helper 17 into alternative T-helper 1 cells. Gastroenterology 2011; 141: 1014-1023. [PMID: 21699791 DOI: 10.1053/ j.gastro.2011.05.052.]
10. Singh B, Read S, Asseman C, Malmström V, Mottet C, Stephens LA, Stepankova R, Tlaskalova H, Powrie F. Control of intestinal inflammation by regulatory T cells. Immunol Rev 2001; 182: 190-200. [PMID: 11722634 DOI: 10.1034/j.1600065X.2001.1820115.x]
11. Mottet C, Uhlig HH, Powrie F. Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells. J Immunol 2003; 170: 3939-3943. [PMID: 12682220]
12. Segain JP, Raingeard de la Blétière D, Sauzeau V, Bourreille A, Hilaret G, Cario-Toumaniantz C, Pacaud P, Galmiche JP, Loirand G. Rho kinase blockade prevents inflammation via nuclear factor kappa B inhibition: evidence in Crohn's disease and experimental colitis. Gastroenterology 2003; 124: 1180-1187. [PMID: 12730857 DOI: 10.1016/S00165085(03)00283-X.]
13. Schmidt N, Gonzalez E, Visekruna A, Kühl AA, Loddenkemper C, Mollenkopf H, Kaufmann SH, Steinhoff U, Joeris T. Targeting the proteasome: partial inhibition of the proteasome by bortezomib or deletion of the immunosubunit LMP7 attenuates experimental colitis. Gut 2010; 59: 896-906. [PMID: 20581238 DOI: 10.1136/gut.]
14. Aswad F, Kawamura H, Dennert G. High sensitivity of CD4+CD25+ regulatory T cells to extracellular metabolites nicotinamide adenine dinucleotide and ATP: a role for P2X7 receptors. J Immunol 2005; 175: 3075-3083. [PMID: 16116196]
15. Sun K, Wang CS, Guo J, Horie Y, Fang SP, Wang F, Liu YY, Liu LY, Yang JY, Fan JY, Han JY. Protective effects of ginsenoside Rb1, ginsenoside Rg1, and notoginsenoside R1 on lipopolysaccharide-induced microcirculatory disturbance in rat mesentery. Life Sci 2007; 81: 509-518. [PMID: 17655881 DOI: 10.1016/j.lfs.2007.06.008]
16. Berrebi D, Languepin J, Ferkdadji L, Foussat A, De Lagausie P, Paris R, Emilie D, Mougenot JF, Cezard JP, Navarro J, Peuchmaur M. Cytokines, chemokine receptors, and homing molecule distribution in the rectum and stomach of pediatric patients with ulcerative colitis. J Pediatr Gastroenterol Nutr 2003; 37: 300-308. [PMID: 12960653]
17. Hegazy SK, El-Bedewy MM. Effect of probiotics on proinflammatory cytokines and NF-kappaB activation in ulcerative colitis. World J Gastroenterol 2010; 16: 4145-4151. [PMID: 20806430 DOI: 10.3748/wjg.]
18. Koh SJ, Kim JS. Prebiotics: germinated barley foodstuff for the prevention of colitis-associated colon cancer? J Gastroenterol Hepatol 2011; 26: 1219-1220. [PMID: 21771059 DOI: 10.1111/j.1440-1746.2011.06769.x.]
19. Furrie E, Macfarlane S, Kennedy A, Cummings JH, Walsh SV, O'neil DA, Macfarlane GT. Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial. Gut 2005; 54: 242-249. [PMID: 15647189 DOI: 10.1136/gut.2004.044834]
20. Campieri M, Gionchetti P. Bacteria as the cause of ulcerative colitis. Gut 2001; 48: 132-135. [PMID: 11115835 DOI: 10.1136/ gut.48.1.132]
21. Chen LL, Wang XH, Cui Y, Lian GH, Zhang J, Ouyang CH, Lu FG. Therapeutic effects of four strains of probiotics on experimental colitis in mice. World J Gastroenterol 2009; 15: 321-327. [PMID: 19140231 DOI: 10.3748/wjg.15.321]
22. Uhlig HH, Coombes J, Mottet C, Izcue A, Thompson C, Fanger A, Tannapfel A, Fontenot JD, Ramsdell F, Powrie F. Characterization of Foxp3+CD4+CD25+ and IL-10-secreting CD4+CD25+ T cells during cure of colitis. J Immunol 2006; 177: 5852-5860. [PMID: 17056509]
23. Liu B, Tonkonogy SL, Sartor RB. Antigen-presenting cell production of IL-10 inhibits T-helper 1 and 17 cell responses and suppresses colitis in mice. Gastroenterology 2011; 141: 653-662, 662.e1-4. [PMID: 21679711 DOI: 10.1053/ j.gastro.2011.04.053.]
24. Kameyama K, Nemoto Y, Kanai T, Shinohara T, Okamoto R, Tsuchiya K, Nakamura T, Sakamoto N, Totsuka T, Hibi T, Watanabe M. IL-2 is positively involved in the development of colitogenic CD4+ IL-7R alpha high memory T cells in chronic colitis. Eur J Immunol 2010; 40: 2423-2436. [PMID: 20623548 DOI: 10.1002/eji.200939764.]
25. Bacchetta R, Passerini L, Gambineri E, Dai M, Allan SE, Perroni L, Dagna-Bricarelli F, Sartirana C, Matthes-Martin S, Lawitschka A, Azzari C, Ziegler SF, Levings MK, Roncarolo MG. Defective regulatory and effector T cell functions in patients with FOXP3 mutations. J Clin Invest 2006; 116: 1713-1722. [PMID: 16741580 DOI: 10.1172/JCI25112]
26. McMurchy AN, Di Nunzio S, Roncarolo MG, Bacchetta R, Levings MK. Molecular regulation of cellular immunity by FOXP3. Adv Exp Med Biol 2009; 665: 30-46. [PMID: 20429414]
27. Himmel ME, Yao Y, Orban PC, Steiner TS, Levings MK. Regulatory T-cell therapy for inflammatory bowel disease: more questions than answers. Immunology 2012; 136: 115-122. [PMID: 22348589 DOI: 10.1111/j.1365-2567.2012.03572.x.]